Authors: KRZAKOWSKI M GRAHAM E GOEDHALS L JOLY F PAWLICKI M RAPOPORT B YELLE L LEES J MCQUADE B

Citation: M. Krzakowski et al., A MULTICENTER, DOUBLE-BLIND COMPARISON OF IV AND ORAL-ADMINISTRATION OF ONDANSETRON PLUS DEXAMETHASONE FOR ACUTE CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 9(7), 1998, pp. 593-598

Authors: JASSEM J ZATLOUKAL P KANITZ E MAGYAR P KRZAKOWSKI M PAWLICKI M PETRUZELKA L CHOVAN L PESEK M KREJCY K

Citation: J. Jassem et al., GEMCITABINE IN LOCALLY ADVANCED AND METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC) - THE CENTRAL-EUROPEAN PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 433-433

Authors: KRZAKOWSKI M GRAHAM E GOEDHALS L PAWLICKI M YELLE L JOLY F

Citation: M. Krzakowski et al., CONTROL OF ACUTE CISPLATIN-INDUCED NAUSEA AND EMESIS USING A ONCE-DAILY ORAL TREATMENT REGIMEN OF ONDANSETRON PLUS DEXAMETHASONE, European journal of cancer, 33, 1997, pp. 67-67

Authors: MADEJ G KRZAKOWSKI M PAWINSKI A LASOTA W ROGOWSKI W SKONECZNA I

Citation: G. Madej et al., A REPORT COMPARING THE USE OF TROPISETRON (NAVOBAN), A 5-HT3 ANTAGONIST, WITH A STANDARD ANTIEMETIC REGIMEN OF DEXAMETHASONE AND METOCLOPRAMIDE IN CISPLATIN-TREATED PATIENTS UNDER CONDITIONS OF SEVERE EMESIS, Seminars in oncology, 21(5), 1994, pp. 3-6

Authors: MADEJ G KRZAKOWSKI M PAWINSKI A LASOTA W ROGOWSKI W SKONECZNA I

Citation: G. Madej et al., A COMPARATIVE-STUDY OF THE USE OF NAVOBAN (ICS 205-930), A 5-HT3 ANTAGONIST, VERSUS A STANDARD ANTIEMETIC REGIMEN OF DEXAMETHASONE AND METOCLOPRAMIDE IN THE TREATMENT OF CISPLATIN-CONTAINING CHEMOTHERAPY, Drug investigation, 6(3), 1993, pp. 162-169